Scottie Resources Corp. (TSXV: SCOT) (OTCQB: SCTSF) (FSE: SR80) ("Scottie" or the "Company") is pleased to announce that ...
GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...
(“NMG” or the “Company”) ( NYSE: NMG, TSX: NOU) has executed a commitment letter in respect of senior secured project debt to support the construction, development and commissioning of the Phase-2 ...
Welcome to the Crinetics Pharmaceuticals Corporate Update Conference Call. [Operator Instructions] I will now turn the call over to Gayathri Diwakar, Head of Investor Relations. Please go ahead. Thank ...
The second phase of “Project Hangang,” a blockchain-based digital currency experiment jointly developed and operated by the ...